-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114992878
August 31, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?pageId=114992878&selectedPageVersions=15&selectedPageVersions=16
September 10, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/diffpages.action?originalId=114991734&pageId=114992878
September 10, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=15&pageId=114990890&revisedVersion=17
September 10, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991761
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991751
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991748
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/plugins/viewsource/viewpagesrc.action?pageId=114991105
October 01, 2021 - evidence and guidance computable—based on the use case of a Collaborative-linked NACHC ambulatory COVID risk … continual enhancement of the ecosystem to utilize it for other focus areas (e.g., anticoagulation, risk … These targets include treatment with anticoagulants and steroids, risk assessment and triage in ambulatory
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=9&pageId=114990890&revisedVersion=17
September 09, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir . net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=7&pageId=114990890&revisedVersion=17
September 09, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114990890
August 04, 2022 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/viewpage.action?pageId=114992878
September 15, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/viewpage.action?navigatingVersions=true&pageId=114992878
September 15, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=13&pageId=114990890&revisedVersion=17
September 10, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/pages/diffpagesbyversion.action?originalVersion=14&pageId=114990890&revisedVersion=17
September 10, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/display/PUB/LHS+Case+Study
August 04, 2022 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence//display/PUB/LHS+Case+Study
August 04, 2022 - COVID-19 Multiplatform RCT EvidenceReport ( https://fevir.net/18816 ): a critically appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( https://fevir.net/18824 ): a critically appraised summary (risk
-
cmext.ahrq.gov/confluence/download/temp/pdfexport-20230227-270223-1032-9/LHS+Case+Study_fb612c1a209540d1a1ed698febd09ae7-270223-1032-10.pdf?contentType=application/pdf
August 31, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( ): a critically https://fevir.net/18816
appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( ): a critically https://fevir.net/18824
appraised summary (risk
-
cmext.ahrq.gov/confluence/download/temp/pdfexport-20230227-270223-2253-647/LHS+Case+Study_15f14f4f24c740bdbdbadc9f42b8815a-270223-2253-648.pdf?contentType=application/pdf
August 31, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( ): a critically https://fevir.net/18816
appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( ): a critically https://fevir.net/18824
appraised summary (risk
-
cmext.ahrq.gov/confluence/download/temp/pdfexport-20230227-270223-2254-649/LHS+Case+Study_e93d59a3824646438f6d8f5bbb6aced5-270223-2254-650.pdf?contentType=application/pdf
August 31, 2021 - COVID-19 Multiplatform RCT EvidenceReport ( ): a critically https://fevir.net/18816
appraised summary (risk … COVID-19 RAPID trial RCT EvidenceReport ( ): a critically https://fevir.net/18824
appraised summary (risk